Lanean...
In Vivo and In Vitro Sustained Release of Ranibizumab from a Nanoporous Thin Film Device
Current administration of ranibizumab and other therapeutic macromolecules to the vitreous and retina carries ocular risks, and a high patient treatment burden, and compliance barriers that can lead to suboptimal treatment. Here we introduce a device that produces sustained release of ranibizumab in...
Gorde:
| Argitaratua izan da: | Drug Deliv Transl Res |
|---|---|
| Egile Nagusiak: | , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5097678/ https://ncbi.nlm.nih.gov/pubmed/27178165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13346-016-0298-7 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|